Exciting drug destroys virulent MRSA
(Photo credit: Destiny Pharma www.destinypharma.com)
Researchers at UK’s Destiny Pharma believe they have developed a drug which can destroy the most virulent strains of MRSA. They are testing the drug code named XF-73 in the hope it can be used in hospitals by 2011.
Study results of the new drug, which is applied as a gel into patients’ noses, showed methicillin-resistant Staphylococcus aureus bacteria (MRSA) did not develop resistance to the compound despite being exposed to it 55 times.
Elaine Warburton www.geneticsandhealth.com
I am colonized with mrsa in my ear, nose, throat gums, lips, axilla, hair, groin, sweat, etc. and experimented with the cholesterol lowering drug Lopid, the generic of which is Gemfibrozil, since I have high tryglecerides and LDL.After taking it for three months, I noticed that it is reacting to my mrsa colonization.I thought it would eradicate the mrsa but seems like it cannot do it by itself.I guess it needs the accompaniment of an antibiotic. I think I just have to wait until they invent a new medication based on this findings more than a month ago. http://www.sciencedaily.com/releases/2008/02/080214144409.htm This is not the same drug that you are talking about, or is it? I also have secondary colonization of klebsiella pneumoniae.
Sometimes, Death Is Good- For A Vicious Unicellular Microorganism
There are a variety of different types of foreign bacterial infections one can get from many different sources, yet some are more common than others. If they are not beneficial for your physiology, they all should die in order to restore your health.
Strept infections are caused by what are called gram positive bacteria, and are unique that these bacteria grow in pairs. Staph bacterial invasions are gram positive as well, yet it is the MRSA, Methicillin Resistant Staff Aureous microbes of this type often are very difficult to treat normally when a patient suffers from their damage from being invaded by these bacteria. Another difficult situation is when a patient is infected by VRE, Vancomycin Resistant Enterococci, bacteria as well.
These MRSA and VRE pathogenic or disease causing bacteria are the ones that are the mos clinically concerning for the health care provider.
Group A strep infections can cause diseases such as strep throat and pneumonia. Since there are several types of bacteria, a diagnostic test called a culture and sensitivity is usually performed to assure the correct antibiotic is selected for treatment, as the bacteria are identified with this method.
Typically, fluid from the area suspected of being infected is obtained from the patient suspected to have an infection and smeared on what is called a petrie dish. And then these dishes are incubated for 2 to 3 days. Gram positive bacteria stain during this process a dark violet or blue. Gram negative bacteria would be pink in color, and are capable of harm as well to a human being.
When the culture is complete, technology offers recommendations on the appropriate class or brand of antibiotic for this bacteria present in another person- presuming the bacteria will not be resistant to the antibiotic recommended, as this happens on occasion.
Usually, classes of antibiotics that are used to treat gram positive strep infections that are not VRE or MRSA are cephalosporins, macrolides, or general penicillins. If the microbe that is causing the infection is resistant to the antibiotic from such classes that are administered to the infected patient, particularly with methicillin and vancomycin, which is the case with VRE and MRSA bacteria, then there are other more aggressive antibiotics that will be chosen for this patient.
Such brands and types of antibiotics for MRSA and VRE bacteria include Zyvox, which has both IV and oral dosage options. There are also other antibiotics, such as cubicin. However these antibiotics for antibiotic resistant bacteria are given usually due to infections that have progressed to a more serious nature within a patient infected in such a way.
Progressive medical conditions include sepsis, or blood infection, osteomyelitis, or bone infection, or Pneumonia, which is a serious lung infection. A hospital stay is normally required with such patients, as the last antibiotics mentioned for MRSA and VRE bacterial infections are given by IV administration initially for several days, if not several weeks.
There are numerous classes and types of antibiotics available, yet bacterial resistance to most of these antibiotics constantly remains serious concern for the health care provider, and the infected patient, with MRSA at the top of the list of concerns for the health care providers.
Dan Abshear